These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10310848)

  • 21. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicare program; end-stage renal disease (ESRD) payment exception requests and organ procurement costs--HCFA. Final rule.
    Fed Regist; 1997 Aug; 62(158):43657-74. PubMed ID: 10169837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal function substitutes. Technical and logistic orientation of the treatment].
    Legrain M; Rottembourg J
    Ann Med Interne (Paris); 1982; 133(8):611-24. PubMed ID: 6763488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Entitlement to Medicare benefits based on end-stage renal disease: final regulation.
    Fed Regist; 1978 Sep; 43(189):44801-4. PubMed ID: 10297231
    [No Abstract]   [Full Text] [Related]  

  • 25. New Medicare payment rules encourage home dialysis, but how to get patients started?
    Neumann ME
    Nephrol News Issues; 2011 Nov; 25(12):17. PubMed ID: 22204163
    [No Abstract]   [Full Text] [Related]  

  • 26. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dilemmas of patient treatment for end-stage renal disease.
    Schmidt RW; Blumenkrantz M; Wiegmann TB
    Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost containment and patient choice in the end stage renal disease program.
    Orr ML
    AANNT J; 1982 Dec; 9(6):11-5. PubMed ID: 6756420
    [No Abstract]   [Full Text] [Related]  

  • 30. Using end-stage renal disease facility surveys to monitor end-stage renal disease program trends. The Data Committee of the National Forum of End-Stage Renal Disease Networks.
    JAMA; 1985 Oct; 254(13):1776-80. PubMed ID: 3897595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The politics of health cost containment: end-stage renal disease.
    Rettig RA
    Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928
    [No Abstract]   [Full Text] [Related]  

  • 32. Rediscovering method II as a reimbursement option.
    Day LM
    Nephrol News Issues; 1998 Oct; 12(10):22-5. PubMed ID: 10196951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of end-stage renal disease in a military setting: experience at Wilford Hall USAF Medical Center, 1977-1981.
    Wilson RL; Springberg PD; Garrett LE; Flanagan MP; Collins CB; Lordon RE
    Mil Med; 1983 May; 148(5):421-5. PubMed ID: 6408522
    [No Abstract]   [Full Text] [Related]  

  • 34. The unique problems of inner-city facilities.
    Hedger RW
    Nephrol News Issues; 1989 Nov; 3(11):21-3. PubMed ID: 2687702
    [No Abstract]   [Full Text] [Related]  

  • 35. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facility reimbursement: a critical comparison between hemodialysis and peritoneal dialysis.
    Fox MP
    Am J Kidney Dis; 1993 Aug; 22(2 Suppl 1):32-4. PubMed ID: 8352270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Home dialysis program costs less than outpatient treatment.
    Blagg CR
    Forum (Wash); 1978; 2(1):20-5. PubMed ID: 417011
    [No Abstract]   [Full Text] [Related]  

  • 38. Medicare program; annual notice of 1982 target reimbursement rates for institutions furnishing home dialysis supplies, equipment, and support services--Health Care Financing Administration. General notice.
    Fed Regist; 1982 Jul; 47(147):33009-13. PubMed ID: 10298790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant.
    Koukounas KG; Kim D; Patzer RE; Wilk AS; Lee Y; Drewry KM; Mehrotra R; Rivera-Hernandez M; Meyers DJ; Shah AD; Thorsness R; Schmid CH; Trivedi AN
    JAMA Health Forum; 2024 Jun; 5(6.9):e242055. PubMed ID: 38944762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost of renal dialysis in a UK setting--a multicentre study.
    Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K
    Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.